GBR-12935 is a novel, potent and selective dopamine reuptake inhibitor and a piperazine derivative.

GBR-12935 is a novel, potent and selective dopamine reuptake inhibitor.

Vanoxerine dihydrochloride (GBR-12909; I-893) is a novel, potent, competitive and highly selective dopamine ruptake inhibitor (Ki=1 nM) with the potential for the treatment of atrial fibrillation.

Dasotraline is a triple reuptake inhibitor that blocks dopamine, norepinephrine, and serotonin transporters with IC50 of 4, 6, and 11 nM, respectively.